IP Library Granted Patent US 7,615,036
Granted Patent B2
US 7,615,036 · App. 11/432,855 · Granted Nov 10, 2009

Device and method for wound therapy

Assignee: Kalypto Medical, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,615,036
App. No.
11/432,855
Granted
Nov 10, 2009
Kind
B2
Abstract

A wound therapy device is disclosed. The wound therapy device may include a housing for covering at least a portion of a wound and for sealing to a body surface of a patient. The housing may also include a liquid-retention chamber for retaining liquid therein and a vacuum connection for coupling to a vacuum source. The vacuum connection may be in gaseous communication with the liquid-retention chamber. The vacuum connection may be separated from the liquid-retention chamber by a liquid barrier.

Claims (35)

1. A wound therapy device, comprising:

a housing to cover at least a portion of a wound site;

a liquid retention chamber position within the housing, wherein the liquid retention chamber collects and stores at least one of liquid exudate and bodily fluid from the wound site, and, wherein the liquid retention chamber retains the collected liquid exudate and bodily fluid stored therein upon application of negative pressure thereto;

an opening in the housing operatively associated with a vacuum source for creating negative pressure within at least the liquid retention chamber; and,

a gas permeable liquid barrier associated with the housing for precluding migration of the liquid exudate and bodily fluid into and through the opening and into the vacuum source.

2. The wound therapy device of claim 1 , further comprising a seal for sealing the housing to a body surface of a patient.

3. The wound therapy device of claim 1 , wherein the housing is constructed of a material having a rigidity sufficient to prevent significant collapse of the liquid retention chamber when subject to a pressure lower than atmospheric pressure.

4. The wound therapy device of claim 3 , wherein the housing material is chosen from a rigid plastic, semi rigid plastic, rigid rubber, semi rigid rubber and combinations thereof.

5. The wound therapy device of claim 1 , wherein the housing comprises a flexible baffler.

6. The wound therapy device of claim 1 , further comprising:

structural supports to prevent significant collapse of the liquid-retention chamber when subject to a pressure lower than atmospheric pressure.

7. The wound therapy device of claim 6 , wherein the structural supports provide support to the housing, and the structural supports are chosen from: customizable rigid and customizable semi-rigid structural supports.

8. The wound therapy device of claim 1 , further comprising structural foam within the liquid-retention chamber to prevent significant collapse of the liquid-retention chamber when subject to a pressure lower than atmospheric pressure.

9. The wound therapy device of claim 1 , wherein the liquid baffler is chosen from: porous polytetrafluoroethylene, microporous polytetrafluoroethylene, porous polypropylene, microporous polypropylene, porous polyethylene, microporous polyethylene, and combinations thereof.

10. The wound therapy device of claim 1 , wherein the liquid barrier is a labyrinth.

11. The wound therapy device of claim 1 , wherein the liquid barrier is a droplet gap.

12. The wound therapy device of claim 1 , wherein the liquid retention chamber further comprises a porous structure for retaining liquid.

13. The wound therapy device of claim 12 , wherein the porous structure is chosen from: a sponge, packing material, a gelling agent, a super-absorbent polymer material and combinations thereof.

14. The wound therapy device of claim 1 , wherein the liquid retention chamber further comprises an antimicrobial agent.

15. The wound therapy device of claim 1 , wherein the opening comprises a vacuum port configured to be coupled to a vacuum supply line.

16. The wound therapy device of claim 1 , wherein the opening is coupled to a micro-vacuum pump disposed adjacent the wound.

17. The wound therapy device of claim 1 , further comprising a pressure relief valve to maintain pressure within the housing.

18. The wound therapy device of claim 17 , wherein the pressure relief valve further comprises an inflow filter.

19. The wound therapy device of claim 1 , wherein a pressure inside the housing is controlled by a switch that deactivates the vacuum source below a lower negative pressure threshold.

20. The wound therapy device of claim 19 , wherein the switch further activates the vacuum source above an upper negative pressure threshold.

21. The wound therapy device of claim 1 , further comprising a fill indicator.

22. The wound therapy device of claim 21 , wherein the fill indicator provides a signal that prompts a deactivation of the vacuum source.

23. The wound therapy device of claim 1 , further comprising an overflow valve.

24. The wound therapy device of claim 1 , wherein the housing is constructed of plastic chosen from: polypropylene, polyurethane, polyvinyl chlorides, polyethylene, acrylonitrile copolymers, nylon, polyester, polychlorotrifluoroethylene, fluoropolymer, and polytetrafluoroethylene and combinations thereof.

25. The wound therapy device of claim 1 , further comprising a wound interface layer.

26. The wound therapy device of claim 25 , wherein the wound interface layer comprises multiple layers.

27. The wound therapy device of claim 25 , wherein the wound interface layer is configured to be disposed adjacent the wound.

28. The wound therapy device of claim 25 , wherein the wound interface layer is at least one of the following: a degradable copolymer foil, dermal regeneration templates, bioabsorbable gels, bioabsorbable foams, tissue adhesion prevention bafflers, a skin substitute, a layer that selectively maintains moisture, an angiogenic layer, and an antimicrobial layer.

29. The wound therapy device of claim 1 , wherein the housing is semi-permeable.

30. The wound therapy device of claim 29 , wherein the semi-permeable housing has a water vapor transmission rate of greater than about 836/m 2 day.

Assignments (6)
MERGER Recorded Dec 14, 2017
From: KALYPTO MEDICAL, INC.
To: SMITH &NEPHEW, INC.
Reel/Frame 044401/0127 →
CHANGE ADDRESS OF ASSIGNEE, KALPTO MEDICAL, INC. Recorded Sep 25, 2009
From: KALYPTO MEDICAL, INC.
To: KALYPTO MEDICAL, INC.
Reel/Frame 023295/0021 →
CHANGE OF NAME Recorded Dec 9, 2008
From: IASIS MEDICAL, LLC
To: IASIS MEDICAL, INC.
Reel/Frame 021942/0864 →
CHANGE OF NAME Recorded Dec 9, 2008
From: IASIS MEDICAL, INC.
To: KALYPTO MEDICAL, INC.
Reel/Frame 021949/0469 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2007
From: CERAMATEC, INC.
To: IASIS MEDICAL, LLC
Reel/Frame 019274/0680 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2006
From: JOSHI, ASHOK V.; GORDON, JOHN H.; DAYTON, TROY C.; BHAVARAJU, SAI
To: CERAMATEC, INC.
Reel/Frame 018411/0978 →
Continuity (1)
Related Publication 20070265585A1 · Nov 15, 2007